Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2
Journal of Medicinal Chemistry · 26.03.2026 · 69 (6) · 6429-6439
DOI: 10.1021/acs.jmedchem.5c02022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 17.03.2026. Verfasst von Naoyuki Suzuki und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan. Hauptthemen laut MEDLINE: Histone Deacetylase 2, Histone Deacetylase 1, Histone Deacetylase Inhibitors, Histones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory for Medicinal Chemistry Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.
- Laboratory for Drug Discovery and Disease Research, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.
- Laboratory for Drug Discovery and Development, Shionogi Pharmaceutical Research Center, 1-1 Futaba-cho 3-chome, Toyonaka, Osaka 561-0825, Japan.
ORCID-Profile: Naoyuki Suzuki, Kazuki Fujimoto, Ken-Ichi Kusakabe
Zitieren
APA
Suzuki, N., Yamakawa, H., Yoshihara, K., Niidome, K., Anan, K., Takaya, K., Kouki, K., Fujimoto, K., Ono, H., Izumi, T., Unemura, K., Ito, M., Hatta, T., Kido, Y., Horiguchi, N., & Kusakabe, K. I. (2026). Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2. Journal of Medicinal Chemistry, 69(6), 6429-6439. https://doi.org/10.1021/acs.jmedchem.5c02022
Vancouver
Suzuki N, Yamakawa H, Yoshihara K, Niidome K, Anan K, Takaya K, et al. Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2. Journal of Medicinal Chemistry. 2026;69(6):6429-6439. doi:10.1021/acs.jmedchem.5c02022
BibTeX
@article{Suzuki2026,
author = {Suzuki, Naoyuki and Yamakawa, Hidekuni and Yoshihara, Ken and Niidome, Kazuki and Anan, Kosuke and Takaya, Kenji and Kouki, Kensuke and Fujimoto, Kazuki and Ono, Hiroko and Izumi, Takaya and Unemura, Kazuhiro and Ito, Mana and Hatta, Takuya and Kido, Yasuto and Horiguchi, Naotaka and Kusakabe, Ken-Ichi},
title = {Discovery of Highly Selective HDAC2 Inhibitors in Cells That Elevate Histone Acetylation In Vivo without Adverse Effects from Dual Inhibition of HDAC1 and 2},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {6},
pages = {6429--6439},
doi = {10.1021/acs.jmedchem.5c02022}
}
EUVIMED